semaglutide oral efficacy First Time: Orally Available GLP-1 Agonist More Effective than DPP-IV Inhibitor | DZD Day 1: Injectables vs. Orals

Current Treatment Options in Gastroenterology, 18 (1), 3342

Vestergaard P, Rejnmark L, and Mosekilde L

Independent testing exposes major differences between brands

Symptomatic vitamin deficiency is more likely if the person is rendered achlorhydric (a complete absence of gastric acid secretion), which occurs more frequently with proton pump inhibitors than H 2 blockers

This study population was then divided into two cohorts: (1) Semaglutide cohort 254 patients prescribed semaglutide, and (2) non-GLP1-RA anti-diabetes medication cohort 7942 patients prescribed non-GLP-1RA anti-diabetes medications but not semaglutide